Similar companies
Company | Transaction Value | |
---|---|---|
Clover HealthCLOV |
$4.1M | |
MetLifeMET |
-$102M | |
AflacAFL |
-$229M | |
ProgressivePGR |
-$1.27B | |
CenteneCNC |
$89M |
Insider Transactions
Name | Transaction Date | Sold / Bought | Shares | Price | Value |
---|---|---|---|---|---|
Kendrick Charles Morgan JR | Oct 18, 2024 | Sell | 7,417 | $432.14 | $3.2M |
PERU RAMIRO G | Aug 5, 2024 | Sell | 753 | $531.52 | $400,000 |
BOUDREAUX GAIL | Jul 22, 2024 | Sell | 20,779 | $500.36 | $10M |
BOUDREAUX GAIL | Jul 22, 2024 | Sell | 6,621 | $501.4 | $3.3M |
BOUDREAUX GAIL | Jul 22, 2024 | Sell | 2,250 | $504.27 | $1.1M |
BOUDREAUX GAIL | Jul 22, 2024 | Sell | 1,100 | $498.5 | $550,000 |
BOUDREAUX GAIL | Jul 22, 2024 | Sell | 1,000 | $503.67 | $500,000 |
Dixon Robert L JR | Jul 19, 2024 | Sell | 305 | $506.76 | $150,000 |
Norwood Felicia F | Apr 24, 2024 | Sell | 3,434 | $532.68 | $1.8M |
Norwood Felicia F | Apr 24, 2024 | Sell | 2,765 | $532.14 | $1.5M |
Norwood Felicia F | Apr 23, 2024 | Sell | 14,011 | $533.73 | $7.5M |
Norwood Felicia F | Apr 23, 2024 | Sell | 100 | $534.74 | $53,000 |
Kendrick Charles Morgan JR | Mar 8, 2024 | Sell | 2,432 | $500.46 | $1.2M |
Penczek Ronald W | Mar 6, 2024 | Sell | 916 | $504.58 | $460,000 |
Haytaian Peter D | Mar 4, 2024 | Sell | 15,000 | $500.18 | $7.5M |
Haytaian Peter D | Mar 4, 2024 | Sell | 4,206 | $500.18 | $2.1M |
Haytaian Peter D | Mar 4, 2024 | Sell | 1,889 | $500.18 | $940,000 |
PERU RAMIRO G | Feb 7, 2024 | Sell | 753 | $500 | $380,000 |
Todt Blair Williams | Dec 14, 2023 | Sell | 5,492 | $484.02 | $2.7M |
Penczek Ronald W | Nov 30, 2023 | Sell | 1,055 | $475.17 | $500,000 |
Penczek Ronald W | Oct 24, 2023 | Sell | 64 | $454.35 | $29,000 |
Dixon Robert L JR | Jul 21, 2023 | Sell | 310 | $476.71 | $150,000 |
MCCARTHY GLORIA M | Mar 24, 2023 | Sell | 5,573 | $445.3 | $2.5M |
MCCARTHY GLORIA M | Mar 24, 2023 | Sell | 3,625 | $446.06 | $1.6M |
MCCARTHY GLORIA M | Mar 24, 2023 | Sell | 3,000 | $444.33 | $1.3M |
MCCARTHY GLORIA M | Mar 24, 2023 | Sell | 1,800 | $443.27 | $800,000 |
MCCARTHY GLORIA M | Mar 24, 2023 | Sell | 600 | $440.78 | $260,000 |
MCCARTHY GLORIA M | Mar 24, 2023 | Sell | 500 | $442.02 | $220,000 |
Kendrick Charles Morgan JR | Mar 9, 2023 | Sell | 2,314 | $462.22 | $1.1M |
What's the latest insider transaction for Elevance Health?
The most recent insider transaction for Elevance Health was conducted by Kendrick Charles Morgan JR, who sold 7,417 shares on October 18, 2024 at a price of $432.14 per share.
Which insider has sold the most ELV stock over the last two years?
BOUDREAUX GAIL has sold the most ELV stock in the last 2 years, with a total value of $16M.
What is the total value of insider transactions for Elevance Health (ELV) in the last 2 years?
The total value of insider transactions for Elevance Health in the last 2 years is negative, amounting to -$54M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Elevance Health's market confidence?
Over the last 2 years, insider transactions for Elevance Health have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.